Banca Mediolanum (BMED) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
2 Jun, 2026Executive summary
Net income for H1 2025 reached €477.3 million, up 6% year-over-year, driven by resilient core business, robust commercial activity, and strong operational performance.
Assets under administration and management rose to €144.4 billion, up 4% from year-end and 12% from June 2024, supported by net inflows of €6.11 billion (+8% YoY) and managed asset inflows up 47%.
Customer base expanded by 3% to nearly 2 million, supported by targeted promotions and growth in the Family Banker network.
Credit book surpassed €18.1 billion, increasing 7% YoY, with a very low NPL ratio of 0.82%.
Commercial volumes rose to €8.08 billion, with loans granted up 48% to €1.86 billion and strong growth in managed assets.
Financial highlights
Net commission income grew 10% YoY to €644.4 million, while net interest income declined 12% to €366.8 million due to lower rates and higher funding costs.
Operating margin increased 1% to €570.6 million; contribution margin up 2% to €1,021.2 million.
Gross commission income rose 11% to €1,104.7 million, with management fees up 10% and banking service fees up 25%.
General insurance gross premiums increased 23% to €114 million.
Loan loss provisions and cost of risk remained low, with cost of risk at 15bps.
Outlook and guidance
2025 guidance: managed asset inflows €8–8.5 billion (raised from €7.5B), net interest income expected to decrease by ~3% YoY.
Cost-to-income ratio targeted below 40% for 2025 and 2026.
Dividend for 2025 anticipated to increase from the €0.75/share base paid in 2024, with potential for a €0.20/share special dividend from Mediobanca stake sale.
NII for 2026 expected at least equal to 2025, with ongoing commercial initiatives and higher-yielding BTPs replacing maturing low-yield securities.
Focus on organic growth, service quality, and process efficiency, with initiatives to strengthen the advisory network.
Latest events from Banca Mediolanum
- Net income up 18% to €674.3M, assets at €133B, CET1 at 23.4%, interim dividend approved.BMED
Q3 20242 Jun 2026 - Net income up 24% to €449.9M, CET1 at 23.7%, and managed asset inflows guidance raised.BMED
Q2 20242 Jun 2026 - Net income up 10–10.4% YoY to €243.3m, with record inflows and strong capital ratios.BMED
Q1 20252 Jun 2026 - Q1 2026 net income up 13%, with strong margins, inflows, and robust capital ratios.BMED
Q1 20267 May 2026 - Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Record net income of €1.12B, €10.44B inflows, and 42% higher dividend proposed.BMED
Q4 20248 Jan 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025